MedPath

Testing THRIVE 365 for Black Sexual Minority Men (On The Daily)

Not Applicable
Completed
Conditions
Emotion Regulation
Anxiety Symptoms
Medication Adherence
Depressive Symptoms
Interventions
Behavioral: iTHRIVE 365
Registration Number
NCT05376397
Lead Sponsor
Rutgers, The State University of New Jersey
Brief Summary

The primary goal of this study is to test a minority stress model of psychological health outcomes for Black sexual minority men (BSMM) while using and not using a novel intervention named THRIVE 365. THRIVE 365 combines mHealth and institutional support elements to provide four areas of support for BSMM: 1) Promote HIV and psychological health knowledge and motivation; 2) Foster a sense of community and positive social connections among BSMM; 3) Connect clients to BSMM-affirming healthcare, including HIV treatment and mental healthcare; 4) Provide resources for housing, transportation, and other economic empowerment. To examine the effects of the intervention, we will utilize a 14-day daily diary study to capture daily intervention engagement, HIV and psychological health outcomes, coping, and experiences of racial and sexual minority stressors. We will first examine main associations between intervention engagement and HIV (antiretroviral treatment use) and psychological health (depressive symptoms, anxiety symptoms, emotion regulation difficulties outcomes) outcomes, then consider how intervention engagement affects coping and attenuates the impacts of racial and sexual minority stressors during the 14 day period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
34
Inclusion Criteria
  • 16 years old or older ;
  • Identifying as masculine
  • Identifying as Black/African American
  • Reporting being attracted to and/or sexually active with men;
  • Able to complete all procedures in English.
  • Mobile access to the internet in order to complete the once-daily survey procedures.
Exclusion Criteria
  • evidence of unstable, unmanaged, or serious psychiatric symptoms that could be made worse by participation;
  • evidence of gross cognitive impairment that would interfere with successful completion of study procedures.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
iTHRIVE 365iTHRIVE 365-
Primary Outcome Measures
NameTimeMethod
Depressive Symptoms24 Hours

The Patient Health Questionnaire-4 assesses anxiety and depressive symptoms. Participants rate the extent to which they had been experiencing each item the past day (e.g., "In the past 24 hours, I've been feeling down, depressed, or hopeless") on a scale from 0 (not at all) to 3 (completely). We used an average across all items for each time point.

Anxiety Symptoms24 Hours

The Patient Health Questionnaire-4 assesses anxiety and depressive symptoms. Participants rate the extent to which they had been experiencing each item the past day (e.g., "In the past 24 hours, I've been feeling nervous, anxious, or on edge") on a scale from 0 (not at all) to 3 (completely). We used an average across all items for each time point.

Emotion Regulation24 Hours

A validated four-item version of the Difficulties with Emotion Regulation Scale assesses emotion regulation. Participants rated the extent to which they had been experiencing each item (e.g., "In the past 24 hours, I've been experiencing my emotions as overwhelming") in the past day on a scale from 0 (not at all) to 3 (completely). We used an average across all items for each time point.

Antiretroviral (ART) Medication Use24 Hours

A single dichotomous no(0)/yes(1) item assesses ART use over the past 24 hours: "In the past 24 hours, did you take ART medication?"

Secondary Outcome Measures
NameTimeMethod
Coping24 Hours

A modified version of the Brief-COPE assesses coping approaches to stress over the last 24 hour. It includes the 3 items from the interconnectedness and 3 items problem-oriented subscales (Greer, 2007), and 3 original items assessing specific interconnectedness with Black LGBTQ people and problem-oriented action against injustice ("I've connected with another Black LGBTQ person for support", "I've spoken out against negative treatment", "I've posted about injustice on social media"). Participant indicate all the coping approaches among the 9 total that they utilized over the last 24 hours (Range: 0-9 coping approaches).

Trial Locations

Locations (1)

Devin English

🇺🇸

Newark, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath